Cellosaurus logo
expasy logo

Cellosaurus K562/MTX-1 (CVCL_F1X6)

[Text][XML][JSON]
Cell line name K562/MTX-1
Accession CVCL_F1X6
Resource Identification Initiative To cite this cell line use: K562/MTX-1 (RRID:CVCL_F1X6)
Comments Population: Caucasian.
Doubling time: 31.5 +- 3.5 hours (PubMed=2465288).
Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
Sequence variations
  • Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
  • Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
Disease Blast phase chronic myelogenous leukemia, BCR-ABL1 positive (NCIt: C9110)
Chronic myeloid leukemia (ORDO: Orphanet_521)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0004 (K-562)
Sex of cell Female
Age at sampling 53Y
Category Cancer cell line
Publications

PubMed=2465288; DOI=10.1111/j.1349-7006.1988.tb01549.x; PMCID=PMC5917644
Shoichi Koizumi;
Impairment of methotrexate (MTX)-polyglutamate formation of MTX-resistant K562 cell lines.
Jpn. J. Cancer Res. 79:1230-1237(1988)

Entry history
Entry creation27-Nov-2025
Last entry update27-Nov-2025
Version number1